2nd Annual Meeting, March 17-19, 2016, Marriott Marquis, NYC
HVS Main Site
Annual Meeting Home
Final Program
Past & Future Meetings

2016 Preliminary Program
Preliminary Program   Moderated Poster Competition   Posters
8.30 - 10.00 Opening Plenary Session: Next Decade in Valve Disease
Moderators: Maurice E. Sarano, MD, President
Gilles D. Dreyfus, MD, President-Elect
Michael A. Borger, MD, Past President
8.30 - 8.35 Welcome
Maurice E. Sarano, MD
8.35 - 8.49 The Epidemics of Valve Disease Will Rise
Bernard Prendergast, MD
8.49 - 9.03 Genetics of Valve Disease Will Be Everything
Robert A. Levine, MD
9.03 - 9.17 Interventional Treatment Will Treat Every Valve Disease
Alec Vahanian, MD
9.17 - 9.31 Tissue Biomechanics Will Tell Us Everything
Jane Grande-Allen, MD
9.31 - 9.45 Robotic Valve Surgery Will Be The Standard Therapy for Degenerative Disease
Rakesh Suri, MD
9.45 - 9.50 Announcement of Borer Travel Awards
Maurice E. Sarano, MD & Jeffery S. Borer, MD
9.45 - 10.00 Presidential Address
Maurice E. Sarano, MD
10.00 - 10.30 Coffee Break & Poster Viewing
10.30 - 12.00 Concurrent Session I: Aortic Stenosis
Moderators: Vinod Thourani, MD
Susheel Kodali, MD
10.30 - 10.42 New natural history and new classification in AS
Luc Pierard, MD
10.42 - 10.54 The new markers of severity of AS (BNP, calcifications)
Philippe Pibarot, DVM, PhD
10.54 - 11.06 Surgical approaches to AVR: is minimally invasive safer?
Vinod Thourani, MD
11.06 - 11.18 Sutureless prostheses: The way of the future…
Michael Borger, MD
11.18 - 11.30 TAVR 2016: How will we tackle periposthetic AR
Susheel Kodali, MD
11.30 - 12.00 Discussion
Concurrent Session II: Aortic Valve Repair: Let's Do It!
Moderators: Emmanuel Lansac, MD
Hans-Joachim Schaefers, MD
10.30 – 10.45 Echocardiographic Predictors of Reparability
Alain Berrebi, MD
10.42 – 10:54 What do I need to know from echo to repair the aortic valve
Gebrine El-Khoury, MD
10.54 – 11.06 Valve-Sparing Root Replacement: Why and How to Do It?
Laurent de Kerchove, MD, PhD
11.06 – 11.18 Isolated Aortic Valve Repair: Why and How to Do It?
Hans-Joachim Schaefers, MD
11.18 – 11.30 Rationales to Standardize Aortic Valve Repair
Emmanuel Lansac, MD
11.30 – 12.00 Discussion
Concurrent Session III: Biomarkers in Valve Disease
Moderators: Marie-Annick Clavel, MD
Mac Dweck, MD
10.30 - 10.45 Natriuretic Peptide in Organic Mitral Regurgitation
Rodolfo Pizarro, MD
10.45 - 11.00 Natriuretic Peptide in Aortic Stenosis
Jutta Bergler-Klein, MD
11.00 - 11.15 Novel Biomarkers for Aortic Stenosis
Brian Lindman, MD
11.15 - 11.30 MicroRNA as Biomarkers in Aortic Stenosis
Magnus Back, MD
11.30 - 12.00 Discussion
Concurrent Session IV: Experience and Innovation in Tissue Engineered Heart Valves Keynote & Abstracts
Moderator: John Mayer, MD
10:30 - 10:45 Keynote
John Mayer, MD
10.45 - 10.55 A1. In-Situ Heart Valve Tissue Engineering - is On-the-fly Preseeding with Bone Marrow-derived Cells Required?
Anthal I.P.M. Smits, Virginia Ballotta, Anita Driessen-Mol, Frank P.T. Baaijens, Carlijn V.C. Bouten.
Eindhoven University of Technology, Eindhoven, Netherlands.
10.55 - 11.05 A2. Performance of Size-Reduced Bicuspidalized Decellularized Pulmonary Valve Conduits in Growing Sheep Model
Karolina Theodoridis, Igor Tudorache, Andres Hilfiker, Tanja Mayer, Samir Sarikouch, Christoph Bara, Alexandru Calistru, Thomas Breymann, Alexander Horke, Axel Haverich, Serghei Cebotari.
Hannover Medical School, Hannover, Germany.
11.05 - 11.15 A3. How Close Are We to Fully Engineering a Living Heart Valve? A Tale of Scaffolds, Stem Cells, Bioreactors and Sheep
Marius M. Harpa1, Ionela Movileanu1, Allison Kennamer2, Nicholas Rierson2, Ovidiu Cotoi1, Horatiu Suciu1, Victor Raicea1, Terezia Preda1, Dan Nistor1, Klara Branzaniuc1, Radu Deac1, Simona Gurzu1, Lucian Harceaga1, Peter Olah1, Carmen Sircuta1, Agneta Simionescu2, Michael Dandel1, Dan Simionescu2.
1University of Medicine and Pharmacy, Targu Mures, Romania, 2Clemson University, Clemson, SC, USA.
11.15 - 11.25 A4. Echocardiographic Leaflet Performance of Stentless Extracellular Matrix Tricuspid Tube graft in a Porcine Model
Diana M. Ropcke, Christine Ilkjaer, Soren N. Skov, Marcell J. Tjornild, Anders V. Sorensen, Henrik Jensen, Sten L. Nielsen.
Aarhus University Hospital, Aarhus C, Denmark.
11.25 - 11.35 A5. Bioresorbable Reinforcement of Neopulmonary Trunk Avoids Sovrapulmonary Stenosis in Arterial Switch Operation: Biomechanics, Growth and Remodelling
Mario Fittipaldi1, Cristiano Spadaccio2, Antonio Nenna3, Massimiliano Fraldi4, Francesco Nappi5.
1Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom, 2Golden Jubilee National Hospital, Glasgow, United Kingdom, 3University Campus Bio-Medico, Rome, Italy, 4University Federico II of Naplesples, Naples, Italy, 5Centre Cardiologique du Nord, Paris, France.
11.35 - 11.45 A6. Bioabsorbable Vascular Graft - the First Step Towards Development of the Next Generation Heart Valves
Leo Bockeria1, Alex Kim1, Konstantin Shatalov1, Vladimir Makarenko1, Oleg Svanidze2.
1Bakoulev Center for Cardiovascular Surgery, Moscow, Russian Federation, 2Xeltis AG, Zurich, Switzerland.
11.45 - 11.55 A7. A Nitinol Mesh Scaffold for Heart Valve Engineering
Seyedhamed Alavi, Marc S. Baliarda, Lorenzo Valdevit, Arash Kheradvar.
University of California, Irvine, Irvine, CA, USA.
Concurrent Session V: Heart Valve Outcomes I Keynote & Abstracts
Moderator(s): Jeffery Borer, MD
10:30 - 10:45 Keynote
Jeffery Borer, MD
10.45 - 10.55 A8. Fresh Decellularized Pulmonary Valve Allografts For Rvot Reconstruction During The Ross Operation - Clinical Outcomes At 10 Years
Francisco D. Costa1, Eduardo Balbi, Filho2, Rafael Torres2, Daniele Colatusso1, Claudinei Colatusso1, Allysson Calixto2, Marise Costa1.
1Santa Casa de Curitiba PUCPR, Curitiba, Brazil, 2Instituto de Neurologia e Cardiologia de Curitiba, Curitiba, Brazil.
10.55 - 11.05 A9. Human Factors During Mitral Valve Replacement Surgery Are Associated With Adverse Events
Jock N. McCullough, MD1, Alexander Iribarne, MD1, David C. Charlesworth, MD2, Robert A. Cough, MD3, Joseph P. DeSimone, MD1, Carmine Frumiento, MD4, Robert S. Kramer, MD5, Bruce J. Leavitt, MD6, Charles A. Marrin, MD1, Jeremy R. Morton, MD5, Joseph D. Schmoker, MD6, Benjamin M. Westbrook, MD2, Anthony W. DiScipio, MD1.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 2Catholic Medical Center, Manchester, NH, USA, 3Eastern Maine Medical Center, Bangor, ME, USA, 4Central Maine Medical Center, Lewiston, ME, USA, 5Maine Medical Center, Portland, ME, USA, 6University of Vermont Medical Center, Burlington, VT, USA.
11.05 - 11.15 A10. Familial Clustering of Mitral Regurgitation in the Community
Francesca N. Delling1, Shuo Li, MS2, Qiong Yang, PhD3, Vanessa Xanthakis, PhD2, Birgitta Lehman, RDCS4, Ewa Osypiuk, MD4, Plamen Stantchev, MD4, Emelia J. Benjamin, MD2, Ramachandran S. Vasan, MD2.
1Beth Israel Deaconess Medical Center, Boston, MA, USA, 2Boston University School of Medicine, Boston, MA, USA, 3Boston University School of Public Health, Boston, MA, USA, 4Framingham Heart Study, Framingham, MA, USA.
11.15 - 11.25 A11. Outcome After Mechanical Aortic Valve Replacement In Adult Patients Under 55 Years: A Systematic Review, Meta-analysis And Microsimulation
Nelleke M. Korteland, Jonathan R.G. Etnel, Bardia Arabkhani, Arezo Mohamad, M. Mostafa Mokhles, Ad J.J.C. Bogers, Johanna J.M. Takkenberg.
Erasmus MC, Rotterdam, Netherlands.
11.25 - 11.35 A12. Computed tomography and Echo evaluation of Left Ventricular Remodeling in Patients with Severe Degenerative Mitral Regurgitation
Zhenhua Li1, Rakesh M. Suri2, Thomas A. Foley3, Eric E. Williamson3, Maurice Enriquez-Sarano1, Hector I. Michelena1.
1Division of Cardiovascular Diseases and Internal Medicine,Mayo Clinic, Rochester, MN, USA, 2Department of Thoracic and Cardiovascular Surgery,Cleveland Clinic, Cleveland, OH, USA, 3Department of Radiology,Mayo Clinic, Rochester, MN, USA.
11.35 - 11.45 A13. Restrictive Indications for the Ross Procedure Improve Long Term Outcomes
Zohair Y. Alhalees, Valeria Pergola, Giovanni Di Salvo, Maie Alshahid, Bahaa Fadel, Mohammed Alamri, Ziad Issa, Mamdouh Alahmadi, Saud Aloufi.
KFSHRC, Riyadh, Saudi Arabia.
11.45 - 11.55 A14. Aortic Valve Replacement - Paradox in Patients With Paradoxical Low Flow
Anthony Poulin, Maxime Berthelot-Richer, Lionel Tastet, Louis Simard, Dimitri Kalavrouziotis, Philippe Pibarot, Marie-Annick Clavel.
Quebec Heart and Lung Institute, Québec, QC, Canada.
12:00 - 13.30 Industry Lunch Symposium
13.30 - 15.00 Concurrent Session I: Great Debates
13.30 - 14.15 Debate I: Functional MR Is Best Treated Percutaneously
Moderators: Paul Sorajja, MD
Michael Borger, MD
13.30 - 13.45 PRO: My favorite is the Mitral Clip
Saibal Kar, MD
13.45 - 14.00 CON: Surgical Repair Is The Standard Of Care
Steven Bolling, MD
14.00 - 14.15 Reconciliation with moderators
14.15 - 15.00 Debate II: TAVR In Low Risk Patients
Moderators: Gregory Fontana, MD
Nicolo Piazza, MD
14.15 - 14.30 PRO Nicolo Piazza, MD
14.30 - 14.45 CON Craig R. Smith, MD
14.45 - 15.00 Reconciliation with moderators
Concurrent Session II: Bicuspid Aortic Valve: Clinical & Basic Science
Moderators: Hector Michelena, MD
Alex Barker, MD
Patrick Mathieu, MD
Rakesh Suri, MD
13.30 - 13.42 New genetic developments: Common and rare genetic variants in BAV
Siddharth Prakash, MD
13.42 - 13.54 The wonders of 4D-flow MR: Ready for clinical use?
Alex Barker, PhD
13.54 - 14.06 Do valvulo-aortic phenotypes predict dissection risk?
Evaldas Girdauskas, MD, PhD
14.06 - 14.18 Embryology of BAV: is there a link with long-term morbidity?
Philippe Sucosky, PhD
14.18 - 14.30 Is BAV repair a durable alternative? For who?
Laurent De Kerchove, MD
14.30 - 15.00 Discussion
Concurrent Session III: Tissue Engineering
Moderators: Carlijn Bouten, MD
Ulrich Stock, MD
13.30 - 13.42 Tissue Engineering of Heart Valves - From In Vitro to In Vivo
Ulrich Stock, MD
13.42 - 13.54 6-Month Aortic Valve Implantation of an Off-The-Shelf Tissue-Engineered Valve in Sheep
Zeeshan Syedain, MD
13.54 - 14.06 Transcatheter off-the-shelf tissue engineered heart valves with self-repair capacity: long term results from a translational ovine model
Max Emmert, MD
14.06 - 14.18 Long-Term In-Vivo Follow Up of Biomaterial-Based In-Situ Heart Valve Tissue Engineering
Carlijn Bouten, MD
14.18 - 14.30 New Approaches in Heart Valve Pathobiology: Implications for Tissue Engineering
Elena Aikawa, MD
14.30 - 15.00 Discussion
Concurrent Session IV: Experimental and Computational Analyses of Valve Disease and Treatment Keynote & Abstracts
Moderator: Ajit Yoganathan, Ph.D.
13.30 - 13.45 Keynote
Ajit Yoganathan, Ph.D.
13.45 - 13.55 A15. A Study of Tunable Biaxial Strain Fields on Aortic Heart Valve Tissues
Ying Lei, Zannatul Ferdous.
The University of Tennessee, Knoxville, TN, USA.
13.55 - 14.05 A16. Infectious Agents related with Collagen Degradation and Inflammation in Myxomatous Mitral Valve Degeneration
Marcos G. Tiveron, Sr., Pablo M. A. Pomerantzeff, Sr., Maria L. Higuchi, Marcia Reis, Jaqueline Pereira, Joyce Kawakami, Renata Ikegami, Carlos M. Brandao, Sr., Fabio B. Jatene, Sr..
Heart Institute, Sao Paulo, Brazil.
14.05 - 14.15 A17. Patient-Specific Computational Modeling of Mitral Valve Repair Techniques
Thuy Pham1, Fanwei Kong1, Caitlin Martin1, Qian Wang1, Charles Primiano2, Raymond McKay2, John Elefteriades3, Wei Sun1.
1Georgia Institute of Technology, Atlanta, GA, USA, 2Hartford Hospital, Hartford, CT, USA, 3Yale University, New Haven, CT, USA.
14.15 - 14.25 A18. Computational Simulation of In Vivo Pulmonary Autograft Early After the Ross Procedure: Wall Stress Analysis
Yue Xuan, PhD1, Hesam S. Moghaddam, PhD1, Ismail El-Hamamsy, MD PhD2, Francois-Pierre Mongeon, MD2, Richard L. Leask, PhD3, Alexander Emmott3, Elaine E. Tseng, MD1, Liang Ge, PhD1.
1UCSF Medical Center and San Francisco VA, San Francisco, CA, USA, 2Montreal Heart Institute and Université de Montréal, Montreal, QC, Canada, 3McGill University, Montreal, QC, Canada.
14.25 - 14.35 A19. Remodeling of Tissue Engineered Heart Valves During a One Year Follow-up Period in Sheep - A Computational Experimental Analysis
Sandra Loerakker1, Bart Sanders1, Boris Schmitt2, Petra E. Dijkman3, Hendrik Spriestersbach2, Anita Driessen-Mol1, Emanuela S. Fioretta1, Marco Bartosch2, Laura Frese3, Simon P. Hoerstrup3, Felix Berger2, Frank P.T. Baaijens1.
1Eindhoven University of Technology, Eindhoven, Netherlands, 2Deutsches Herzzentrum Berlin, Berlin, Germany, 3University and University Hospital Zurich, Zurich, Switzerland.
14.35 - 14.45 A20. A New Fluid-Structure Interaction Model for Bicuspid Aortic Valves
Karin Lavon1, Rotem Halevi1, Gil Marom2, Sagit Ben Zekry3, Rami Haj-Ali1, Hans Joachim Schäfers4, Ehud Raanani5.
1School of Mechanical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel, 2Biomedical Engineering Department, Stony Brook University, 11794, NY, USA, 3Echocardiography Laboratory, Chaim Sheba Medical Center, Tel Hashomer, Israel, 4Department of Thoracic and Cardiovascular Surgery, University Hospitals of Saarland, Homburg, Germany, 5Department of Cardio- thoracic Surgery, Chaim Sheba Medical Center, Tel Hashomer, Israel.
14.45 - 14.55 A21. Initial Impact of Bicuspid Aortic Valve Morphotype on Ascending Aorta Hemodynamics: an In Vitro Study
Andrew McNally1, Philippe Sucosky2.
1University of Notre Dame, South Bend, IN, USA, 2Wright State University, Dayton, OH, USA.
Concurrent Session V: Heart Valve Repair Keynote & Abstracts
Moderator: Ottavio Alfieri, MD
13:30 - 13:45 Keynote
Ottavio Alfieri, MD
13.45 - 13.55 A22. Ten Year Single Center Experience with Robotic Assisted Mitral Valve Repair
Alfredo Trento, MD, Danny Ramzy, MD, PhD, Michele De Robertis, RN, James Mirocha, MS, Wen Cheng, MD, Lawrence Czer, MD.
Cedars-Sinai Medical Center, Los Angeles, CA, USA.
13.55 - 14.05 A23. Remodeling Associated With Aortic Ring Annuloplasty: Long Term Results of a Physiological Approach to Valve Sparing
Emmanuel LANSAC1, Isabelle Di Centa2, Ghassan Sleilaty1, Stéphanie Lejeune1, Nizar Khelil1, Alain Berrebi1, Christelle Diakov1, Leila Mankoubi1, Marie Christine Malergue1, Milena Noghin1, Konstantinos Zannis1, Suzanna Salvi1, Patrice Dervanian1, Mathieu Debauchez1.
1Institut Mutualiste Montsouris, PARIS, France, 2Hopital Foch, Suresnes, France.
14.05 - 14.15 A24. Predictors of New-Onset Atrial Fibrillation in Preserved Ejection Fraction Patients Undergoing Isolated Mitral Valve Repairs
J. Trent Magruder, Sarah Collica, Stephen Belmustakov, Todd C. Crawford, Joshua C. Grimm, Duke E. Cameron, William A. Baumgartner, Kaushik Mandal.
Johns Hopkins, Baltimore, MD, USA.
14.15 - 14.25 A25. Combined Mitral and Aortic Valve Reconstruction
Alexander Wick, Diana Aicher, Christian Giebels, Takahashi Kunihara, Hans-Joachim Schäfers.
Saarland University, Homburg, Germany.
14.25 - 14.35 A26. Mitral Stenosis After Mitral Valve Repair For Degenerative Disease May Limit Exercise Capacity
Kiyoshi Doi, Hitoshi Yaku, Satoshi Numata, Sachiko Yamazaki, Keiichi Itatani, Suguru Ohira, Kaichiro Manabe, Kiminori Ikemoto, Tetsuhiro Yamano.
Kyoto Prefectural University of Medicine, Kyoto, Japan.
14.35 - 14.45 A27. Tricuspid Valve Repair: What to Do When a Ring Is Not Enough.
Matteo Pettinari, Philip Bertrand, Herbert Gutermann, Christiaan Van Kerrebroeck, Robert Dion.
Ziekenhuis Oost Limburg, Genk, Belgium.
14.45 - 14.55 A28. Early Echocardiographic Outcomes of Mitral Valve Annuloplasty versus Annuloplasty Combined with a Papillary Muscle Sling for Moderate to Severe Functional Mitral Regurgitation
Christos G. Mihos1,2, Romain Capoulade1, Evin Yucel1, Serguei Melnitchouk1, Judy Hung1.
1Massachusetts General Hospital, Boston, MA, USA, 2Coulmbia University, Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL, USA.
15:00 - 15:30 Coffee Break & Poster Viewing
15.30 - 17.00 Concurrent Session I: Rapid Fire: Mitral and Tricuspid Innovation
Moderator: David Meerkin, MD
Vinod Thourani, MD
Gilles Dreyfus, MD
Alec Vahanian, MD
In-Audience Moderators: Maurice E. Sarano, MD
Hector Michelena, MD
15.30 - 15.35 Percutaneous annuloplasty of TR
Gino Nicenig, MD
15:35 - 15:40 The 4Tech approach to TR
Paolo Denti, MD
15.40 - 15.45 Off-pump chordal implant
Gino Gerosa, MD
15.45 - 15:50 Epicardial devices approach for functional MR
Jai Ramen, MD
15:50 - 15:55 The Valtech Cardioband implantation
Francesco Maisano, MD
15:55 - 16:00 Mitral Bridge
Valavanur Subramanian, MD
16:00 - 16:05 Adjustable mitral annuloplasty
Carlos Ruiz, MD
16:05 - 16:10 Docking the TMVR
Rebecca Halm
16:10 - 16:20 Edwards CardiAQ transcatheter mitral valve replacement
Issac George, MD
16.20 - 16.25 The Tendyne TMVR
Paul Sorajja, MD
16.30 - 16.35 The Twelve Mitral Prosthesis
Bernard Prendergast, MD
16.30 - 17.00 Discussion
Concurrent Session II: Rheumatic Disease & Global Epidemiology
Moderators: Vuyisile Nkomo, MD
Liesl Zuhlke, MD
Bernard Prendergast, MD
15.30 - 15.42 Epidemiology of Rheumatic Heart Disease - Lessons from the Global Burden of Disease
David Watkins, MD
15.42 - 15.54 The Clinical Burden of Rheumatic Heart Disease - Insights from the REMEDY Study
Liesl Zuhlke, MD
15.54 - 16.06 Genetic Determinants of Rheumatic Fever and Rheumatic Heart Disease
Andrea Beaton, MD
16.06 - 16.18 Rheumatic Heart Disease in Samoa
Marvin Allen, MD
16.18 - 16.30 Rheumatic Heart Disease Collaboration in Mozambique
Daniel Sidi, MD
16.30 - 17.00 Discussion
Concurrent Session III: Mechanisms & Prevention of Bioprosthetic Degeneration
Moderator: Robert Levy, MD
Jean-Christian Roussel, MD
15.30 - 15.42 The Pathophysiologic Determinants of How and Why Valve Bioprostheses Fail
Gaetano Thiene, MD
15.42 - 15.54 Bioprosthetic Heart Valve Structural Degradation: Biomechanical Mechanisms, Modeling, Performance
Michael Sacks, Ph.D.
15.54 - 16.06 The Impact of Oxidative Modifications on Non-Calcific Bioprosthetic Heart Valve Failure
Giovanni Ferrari, Ph.D.
16.06 - 16.18 Immunogenic non-human carbohydrate antigen expression in bioprostheses. Potential link to structural deterioration
Vered Padler-Karavani, Ph.D.
16.18 - 16.30 Pathogenesis and Mitigation of Bioprosthetic Structural Degeneration Due to Mineralization
Robert Levy, MD
16.30 - 17.00 Discussion
Concurrent Session IV: 3-D Echo Imaging
Moderators: Joseph Maalouf, MD
Francesco Faletra, MD
Alain Berrebi, MD
15.30 - 15.42 The Incremental Value of 3D Echocardiography for Valve Analysis of Mitral and Aortic Regurgitation
Alain Berrebi, MD
15.42 - 15.54 Benefits of Imaging the Tricuspid Valve Using 3D Echocardiography
Rebecca Hahn, MD
15.54 - 16.06 The Evolving Role of 3D TEE in Transcatheter Edge-to-Edge Mitral Valve Repair
Joseph Maalouf, MD
16.06 - 16.18 The Role of 3D TEE in Guiding Transcatheter Closure of Mitral Periprosthetic Leaks and Valve-in-valve Implantation
Sunil Mankad, MD
16.18 - 16.30 New Trends in Echo-Guiding Percutaneous Procedures: The X-Ray-3D Echo Fusion Imaging
Francesco Faletra, MD
16.30 - 17.00 Discussion
Concurrent Session V: Endocarditis
Moderators: Mariana Mirabel, MD
Milind Desai, MD
15.30 - 15.42 Prophylaxis of Infective Endocarditis
Ann Bolger, MD
15.42 - 15.54 Incremental Value of Multimodality Imaging in IE
Milind Desai, MD
15.54 - 16.06 Endocarditis Team
Milind Desai, MD
16.06 - 16.18 CDRIE
Charles Love, MD
16.18 - 16.30 Timing of Valve Surgery in Adults
Jean-Francois Obadia, MD
16.30 - 16.35 Worldwide Challenges in IE
Mariana Mirabel, MD
16.35 - 17.00 Discussion
17:00 - 17.30 Annual Business Meeting
17.30 - 19:00 Welcome Reception & Moderated Poster Competition
8.30 - 10.00 Concurrent Session I: Degenerative MR
Moderators: Francesco Grigioni, MD
David Adams, MD
8.30 - 8.42 Anatomy and Physiopathology Through Different Imaging Modalities
Vuyisile Nkomo, MD
8.42 - 8.54 Natural History Studies and Indications for Surgery
Francesco Grigioni, MD
8.54 - 9.06 Mitral Repair is Always the Preferred Sugical Technique to Treat Degenerative Mitral Regurgitation (or Maybe Not)
David Adams, MD
9.06 - 9.18 Percutaneous Treatment of Degenerative Mitral Regurgitation: Where Do We Stand and Where Should We Go?
Francesco Maisano, MD
9.18 - 9.30 Rational and Potential Benefits of Minimally Invasive Surgery
Didier Loulmet, MD
9.30 - 10.00 Discussion
Concurrent Session II: Managing Complications of Transcatheter Valve Therapies
Moderators: Jeorg Kemfert, MD
Matthew Verghese, MD
8.30 - 8.40 Valve Embolization
Gurpreet Sandhu, MD
8.40 - 8.50 TAVR Related Mitral Regurgitation
Verghese Matthew, MD
8.50 - 9.00 Aortic Annular Rupture/TAVR Castastrophe
Kevin Greason, MD
9.00 - 9.10 Aortic Dissection
Norman Mangner, MD
9.10 - 9.20 Annular Rupture: How to avoid and how to manage
Axel Unbehaun, MD
9.20 - 9.30 Stroke during TAVR
Jorg Kempfert, MD
9.30 - 10.00 Discussion
Concurrent Session III: Valve Calcification: Clinical & Basic Science
Moderators: Jordan Miller, MD
David Messika-Zeitoun, MD
8.30 - 8.45 Animal Models of Valve Disease: Great Utility or Ultimate Futility?
Jordan Miller, MD
8.45 - 9.00 Leveraging the Genetics of Valve Calcification at the Dawn of Precision Medicine
Yohan Bosse, MD
9.00 - 9.15 Deriving Prognostic Information from Vlave Calcification: "The Doctor Will CT You Now…."
David Messika-Zeitoun, MD
9.15 - 9.30 New Imaging Modalities in Valve Disease: The Next Wave of Actionable Intelligence
Marc Dweck, MD
9.30 - 10.00 Discussion
Concurrent Session IV: Heart Valve Imaging Keynote & Abstracts
Moderator: Jim Thomas, MD
8.30 - 8.45 Keynote
Jim Thomas, MD
8.45 - 8.55 A29. Assessment of Myocardial Fibrosis in Aortic Stenosis using Cardiac Magnetic Resonance Imaging
Calvin Chin1, Russell J. Everett2, Jacek Kwiecinski3, Alex Vesey2, Emily Yeung2, Gavin Esson2, William Jenkins2, Maria Koo2, Saeed Mirsadraee2, Audrey White2, Alan Japp2, Sanjay Prasad4, Scott Semple5, David Newby2, Marc Dweck2.
1Department of Cardiovascular Science,National Heart Center, Singapore, Singapore, 2University of Edinburgh, Edinburgh, United Kingdom, 3First Department of Cardiology, Poznan University of Medical Sciences, Poland, Poland, 4Royal Brompton Hospital, London, United Kingdom, 5Clinical Research Imaging Centre, Edinburgh, United Kingdom.
8.55 - 9.05 A30. Causes and Mechanisms of Isolated Mitral Regurgitation in the Community: Impact and Outcome
Volha Dziadzko, Marie-Annick Clavel, Maurice Enriquez-Sarano.
Mayo Clinic, Rochester, MN, USA.
9.05 - 9.15 A31. Aortic Valve Stenosis Complicates the Hemodynamic Hypothesis for Regional Bicuspid Aortic Valve Aortopathy Development
Alex J. Barker1, Pim van Ooij2, Emilie Bollache1, S Chris Malaisrie1, Patrick M. McCarthy1, Jeremy Collins1, James Carr1, Paul W. M. Fedak3, Michael Markl1.
1Northwestern University, Chicago, IL, USA, 2Amsterdam Medical Center, Amsterdam, Netherlands, 3University of Calgary, Calgary, AB, Canada.
9.15 - 9.25 A32. Low Ejection Fraction, Low-Flow, Low-Gradient Aortic Stenosis: Dobutamine Stress Echocardiographic Criteria to Assess Stenosis Severity
Eden Touboul1, Abdellaziz Dahou1, Ian Burwash2, Maurice Enriquez-Sarano3, Jutta Bergler-Klein4, Stefan Orwat5, Helmut Baumgartner5, Gerald Mundigler4, Eric Larose1, Philippe Pibarot1, Marie-Annick Clavel1.
1IUCPQ, Quebec, QC, Canada, 2Ottawa Heart Institute, Ottawa, ON, Canada, 3Mayo CLinic, Rochester, MN, USA, 4Vienna General Hospital, Vienna, Austria, 5Muenster general hospital, Muenster, Germany.
9.25 - 9.35 A33. The En-Face Quantitative Analysis of Valvular Calcification; Novel Physiological Insights into Aortic Stenosis using 4-dimensional Computed Tomography.
William S. Jenkins1, Louis Simard2, Jérome Hourdain2, Marie-Annick Clavel2, Maurice Enriquez-Sarano1.
1Mayo Clinic, Rochester, MN, USA, 2Laval University, Quebec, QC, Canada.
9.35 - 9.45 A34. Prognostic Value of Longitudinal Strain in Asymptomatic Aortic Stenosis and Preserved Left ventricular Ejection Fraction - The COFRASA/GENERAC Study
Maria Melissopoulou, Virginia Nguyen, Tiffany Mathieu, David Attias, Julien Dreyfus, Isabelle Codogno, Alec Vahanian, David Messika-Zeitoun.
Bichat Claude Bernard Hospital, Paris, France.
9.45 - 9.55 A35. Non-Invasive Assessment of Paravalvular Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Based on Energy Loss
Ali N. Azadani1, Peyman N. Azadani2.
1University of Denver, Denver, CO, USA, 2University of Utah School of Medicine, Salt Lake City, UT, USA.
Concurrent Session V: Heart Valve Outcomes II Keynote & Abstracts
Moderator: Jose Pomar, MD
8.30 - 8.45 Keynote
Jose Pomar, MD
8.45 - 8.55 A36. Early Versus Delayed Surgery for Patients with Valvular Infective Endocarditis Complicated by Embolic Ischemic Cerebrovascular Events: A Meta-Analysis of 14 Studies
Christos G. Mihos1, Andres M. Pineda2, Orlando Santana2.
1Massachusetts General Hospital, Boston, MA, USA, 2Coulmbia University, Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL, USA.
8.55 - 9.05 A37. Matched Comparison of Self Expanding Transcatheter Heart Valves for the Treatment of Failed Surgical Aortic Bioprosthesis: Insights from the Valve in Valve International Data (VIVID) Registry.
Sami M. Alnasser1, Asim Cheema1, Ran Kornowski2, Matheus Simonato3, Thomas Walther4, Azeem Latib5, Luca Testa6, JeanClaude Laborde7, David Hildick Smith8, Marco Barbanti9, WonKeun Kim10, Francesco Bedogni11, Hafid Amrane12, A. J. van Boven13, Marc Pelletier14, Josep RodesCabau15, Joelle Kefer16, Christian Frerker17, Nicolas M Van Mieghem18, Ganesh Manoharan19, Stephen G Worthley20, Anita W Asgar21, carmelo sgroi22, John Webb23, Danny Dvir24.
1University of Toronto, Toronto, ON, Canada, 2Rabin Medical Center, Tel Aviv, Israel, 3Escola Paulista de Medicina, Sao Paulo, Brazil, 4Kerckhhoff Heart Center, Bad Nauheim, Germany, 5Ospedale San Raffaele, Milan, Italy, 6Istituto Clinico S. Ambrogio, Milan, Italy, 7St.George hospital, London, Plumtree Nottingham, United Kingdom, 8Royal Sussex County Hospital, Brighton, United Kingdom, 9Ferrarotto Hospital, University of Catania, Catania, Italy, 10Kerckhoff Heart Center, Bad Nauheim, Germany, 11Istituto Clinico S Ambrogio, Milan, Italy, 12Medisch Centrum, Leeuwarden, Netherlands, 13Medisch Centrum Leeuwarden, Leeuwarden, Netherlands, 14New Brunswick Heart Center, Saint John, NB, Canada, 15Quebec Heart and Lung Institute, Laval, QC, Canada, 16Cliniques SaintLuc, Université Catholique de Louvain, Brussels,, Belgium, 17Asclepios Clinic St. Georg, Hamburg, Germany, 18Erasmus MC, Rotterdam, Rotterdam, Netherlands, 19Royal Victoria Hospital, Belfast, United Kingdom, 20The University of Adelaide,, Adelaide, Australia, 21Montreal Heart Institute, Montreal, QC, Canada, 22FERRAROTTO'S HOSPITAL,, CATANIA, Italy, 23St Pauls Hospital, Vancouver, BC, Canada, 24St Paul's Hospital, Vancouver, BC, Canada.
9.05 - 9.15 A38. Transcatheter Mitral Valve Implantation: One Year Outcomes of the First-In-Man Experience with an Apically Tethered Device
Alison Duncan, Cesare Quarto, Simon Davies, Anselm Uebing, Neil Moat.
The Royal Brompton Hospital, London, United Kingdom.
9.15 - 9.25 A39. Conventional Mitral Valve Surgery in MitraClip Candidates
Thilo Noack, Yamen Al Ghanam, Philipp Kiefer, Fabian Emrich, Philipp Lurz, David M. Holzhey, Farhad Bakhtiary, Martin Misfeld, Gerhard Schuler, Friedrich-Wilhelm Mohr, Joerg Seeburger.
Heart Center Leipzig University, Leipzig, Germany.
9.25 - 9.35 A40. Epidemiology of Valvular Heart Diseases: A 30-year Retrospective of Hospitalizations and In-Hospital Mortality in New York State
Phyllis G. Supino, EdD, Ofek Y. Hai, DO, Jeffrey S. Borer, MD.
SUNY Downstate Medical Center, Beverly, MA, USA.
9.35 - 9.45 A41. Right Ventricular Function by Speckle Tracking and Outcomes In Low-flow, Low Gradient Aortic Stenosis with Low LVEF
Abdellaziz Dahou1, Marie-Annick Clavel1, Romain Capoulade2, Philipp E. Bartko2, Julien Magne3, Gerald Mundigler4, Jutta Bergler-Klein4, Ian Burwash5, Julia Mascherbauer4, Henrique B. Ribeiro1, Kim O'Connor1, Helmut Baumgartner6, Mario Senechal1, Jean G. Dumesnil7, Raphael Rosenhek4, Josep Rodés-Cabau1, Philippe Pibarot1.
1QUÉBEC HEART-LUNG INSTITUTE, QUÉBEC, QC, Canada, 2Massachusetts General Hospital, Boston, MA, USA, 3Centre Hospitalier Universitaire Limoges, Limoges, France, 4Division of Cardiology, Medical University of Vienna, Vienna, Austria, 5University of Ottawa Heart Institute, Ottawa, ON, Canada, 6Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany, 7Laval University, QUÉBEC, QC, Canada.
9.45 - 9.55 A42. Does The Use Of A Decision Aid Improve Decision Making In Prosthetic Heart Valve Selection? A Multicenter Randomized Clinical Trial
Nelleke M. Korteland1, Yunus Ahmed2, David R. Koolbergen2, Marjan Brouwer3, Frederiek de Heer3, Jolanda Kluin3, Eline F. Bruggemans4, Robert J.M. Klautz4, Anne M. Stiggelbout4, Jeroen J.J. Bucx5, Ad J.J.C. Bogers1, Johanna J.M. Takkenberg1.
1Erasmus MC, Rotterdam, Netherlands, 2AMC, Amsterdam, Netherlands, 3UMC Utrecht, Utrecht, Netherlands, 4LUMC, Leiden, Netherlands, 5Diakonessenhuis, Utrecht, Netherlands.
10:00 - 10:30 Coffee Break & Poster Viewing
10.30 - 12.00 Concurrent Session I: Dystrophic Aortic Insufficiency: Limits of Current Guidelines
Moderators: Emmanuel Lansac, MD
Jean Louis Vanoverschelde, MD
10.30 - 10.40 The LV dysfunction in AR: New ways to assess and decide when to operate?
Linda Giliam, MD
10.40 - 10.50 Quantification of AR: the heart of the matter
Marta Sitges, MD
10.50 - 11.00 Aortic root aneurysm: How to measure, when and how to operate
Thoralf M Suundt, MD
11.00 - 11.10 MRI Aortic Compliance and Risk of Dissection
Emilie Bollache, MD
11.10 - 11.20 Tricuspid aortic valve reapir: Is It Worthwile?
Jan Vojacek, MD
11.20 - 11.30 Bicuspid aortic valve repair: Is It Worthwhile?
Ismail El-Hamamsy, MD
Concurrent Session II: Mitral Valve Prolapse: Clinical & Basic Science
Moderators: Susan Slaugenhaupt, MD
Russell Norris, MD
Robert Levine, MD
10.30 - 10.42 Serotonergic Regulation of Mitral Valve Prolapse
Robert Levy, MD
10.42 - 10.54 Identification of the Cilia Gene, DZIP1, in a large family with Non-syndromic MVP
David Milan, MD
10.54 - 11.06 Genetic Landscape and Sporadic Mitral Valve Prolapse: Unifying Concepts for Disease Etiology?
Nabila Bouatia-Naji, MD
11.06 - 11.18 Familial MVP Studies Lead to New Candidate Disease Genes
Jean-Jacques Schott, MD
11.18 - 11.30 Translating Genetic and Biological Discoveries into Remidial Therapies for MVP
Roger Markwald, MD
11.30 - 12.00 Discussion
Concurrent Session III: Achieving Regulatory Approval
Moderators: Jeffrey S. Borer, MD
Wei Sun, Ph.D
10.30 - 10.40 Medical Device Regulatory Essentials: Approval pathways for indication expansions and sub-populations?
Nicole Ibrahim, MD
10.40 - 10.50 Preclinical and Bench Testing - What Can be Inferred?: New Technical Developments
Changfu Wu, PhD
10.50 - 11.00 What can we expect from VARC-3?
11.00 - 11.10 ISO Guidances for Industry and Regulatory Approval Standards: How do They Intersect? Role of modeling
Francis Duray, PhD
11.10 - 11.20 The CE Mark Process - Feasibility Demonstration or Proof of Performance/Safety? How to Select Minimal Sample Sizes?
Bassil Akra, MD
11.20 - 11.30 How Does Industry Respond to Development Issues Involving Two Disparate Approval Systems
11.30 - 12.00 Discussion
Concurrent Session IV: Mechanical Valve & Anticoagulation
Moderators: Hector Michelena, MD
Sabrina Phillips MD
Bernard Lung, MD
10.30 - 10.45 Mechanical Valve and Pregnant: What to do?
Sabrina Phillips, MD
10.45 - 11.00 New Anticoagulants and Mechanical Valves: Compatible?
Waldemar Wysokinski, MD
11.00 - 11.15 Do Mechanical Valves Thrombose More Than Bioprostheses?
Sorin Pislar, MD
11.15 - 11.30 Can I recommend a lower INR target or aspirin and clopidogrel?
John Puskas, MD
11.30 - 12.00 Discussion
Concurrent Session V: Minimally Invasive Valve Surgery Keynote & Abstracts
Moderator: W. Randolph Chitwood, MD
10:30 - 10:45 Keynote
W. Randolph Chitwood, MD
10.45 - 10.55 A43. Minimal Invasive and Sutureless Technology: Are These Advantages for Patients Undergoing Aortic Valve Replacement?
Steffen Pfeiffer, Joachim Sirch, Jurij M. Kalisnik, Ferdinand Vogt, Theodor Fischlein, Giuseppe Santarpino.
Klinikum Nürnberg, Paracelsus Medical University, Nuremberg, Germany.
10.55 - 11.05 A44. Minimally Invasive Versus Conventional Extracorporeal Circulation In Minimally Invasive Mitral Valve Surgery
Christian J. Rustenbach, Ulrich F.W. Franke, Ragi Nagib, Samir Ahad, Adrian Ursulescu, Hardy Baumbach.
Robert-Bosch-Hospital, Stuttgart, Germany.
11.05 - 11.15 A45. Minimally Invasive Mitral Valve Surgery: Technique of Choice for Cardiac Reoperations
Davide Ricci, Cristina Barbero, Giovanni Marchetto, Suad ElQarra, Massimo Boffini, Mauro Rinaldi.
AOU Città della Salute e della Scienza di Torino - University of Turin, Turin, Italy.
11.15 - 11.25 A46. Transcatheter Aortic Valve Replacement in Patients with Pulmonary Hypertension
Mohammad Rajaei1, Jose Condado2, Hanna Jensen1, Jose Binongo3, Chandan Devireddy2, Bradley Leshnower1, Jessica Forcillo1, Stamatios Lerakis2, Eric Sarin1, Kreton Mavromati2, Robert Guyton1, James Stewart2, Peter Block2, Lillian Tsai1, Amy Simone1, Patricia Keegan1, Vasilis Babaliaros2, Vinod Thourani1.
1Emory Structural Heart and Valve Center, Joseph B. Whitehead Department of Surgery, Division of Cardiothoracic Surgery, Atlanta, GA, USA, 2Emory Structural Heart and Valve Center, Department of Medicine, Division of Cardiology, Atlanta, GA, USA, 3Emory University Rollins School of Public Health, Atlanta, GA, USA.
11.25 - 11.35 A47. Is there an Impact on Postoperative Morbidity and Long Term Survival after Minimal Access Aortic Valve Replacement
Sven Lehmann, Denis R. Merk, Sergey Leontyev, Christian Etz, Martin Misfeld, Martin Haensig, Anna K. Funkat, Jens Garbade, Friedrich W. Mohr.
Heartcenter Leipzig, Leipzig, Germany.
11.35 - 11.45 A48. New Transcervical Approach to Transcatheter Mitral Valve Replacement (TMVR) using CoreVista System
Cristiano Spadaccio, Fraser W. Sutherland.
Golden Jubilee National Hospital, Glasgow, United Kingdom.
11.45 - 11.55 A49. Aortic Valve Replacement via Right Mini-Thoracotomy: Is it Really Minimally Invasive?
Mauro Del Giglio, Simone Calvi, Simone Turci, Marco Pagliaro, Marco Panzavolta, Elisa Mikus.
Maria Cecilia Hospital, GVM for Care & Research, Cotignola (Ra), Italy.
12:00 - 13:30 Industry Lunch Symposium
13.30 - 15.00 Concurrent Session I: Great Debates
13.30 - 14.15 Debate I: Robotic
Moderators: Husam Balkhy, MD
Rakesh Suri, MD
13.30 - 13.45 I Do Not Need Robotic Approach
David Adams, MD
13.45 - 14.00 Patients Adore Robotic Repair
Doug Murphy, MD
14.00 - 14.15 Reconciliation with moderators
14.15 - 15.00 Debate II: Low Gradient Normal EF Severe Aortic Stenosis
Moderator: David Messika-Zeitoun, MD
Maurice Enriquez-Sarano, MD
14.15 - 14.30 Severe AS Low-Gradient Does Not Exist
Jene Louis Vanoverschelde, MD
14.30 - 14.45 Severe AS Low-Gradient Is Genuine and Requires Treatment
Phillippe Pibarot, DVM, PhD
14.45 - 15.00 Reconciliation with moderators
Concurrent Session II: Ischemic Functional MR: New Paradigms From Mechanism to Treatment
Moderators: Nozomi Watanabe, MD
Judy Hung, MD
13.30 - 13.42 How Big is the Problem? Demographics and Prognosis of Ischemic Functional MR?
Judy Hung, MD
13.42 - 14.00 Secondary/Ischemic/Functional/Type 3b? How Do We Define and Recognize It? Imaging Features
Nozomi Watanabe, MD

Who Should We Fix? How Should We Fix It? Lessons Learned from the CTSN Trials:

14.00 - 14.15 Severe MR
Michael Acker, MD
14.15 - 14.30 Moderate MR
Robert Michler, MD
14.30 - 14.45 Subvalvular Approaches to MV Repair for Ischemic MR
Gorav Ailawadi, MD
14.45 - 15.00 Discussion
Concurrent Session III: Transcatheter Valve Implantation in Failed Bioprostheses/Rings: The Valve-in-Valve Approach
Moderators: Danny Dvir, MD
Elaine Tseng, MD
13.30 - 13.40 Failure of Surgical Valves: The Scope of the Problem
Marie Annick Clavel, MD
13.40 - 13.50 In Vitro Assessment of Edwards Sapien XT vs. Medtronic Corevalve in Surgical Bioprostheses
Ulrich Steinseifer, MD
13.50 - 14.00 Introduction to Valve-In-Valve Therapies: What Does Clinical Data Show?
Danny Dvir, MD
14.00 - 14.10 Elevated Gradients: The "Achilles' Heel" of Valve in Valve Procedures
Sabine Bleiziffer, MD
14.10 - 14.20 Mitral Valve in Valve/Valve in Ring
Ehud Rannani, MD
14.20 - 14.30 Tricuspid Valve in Valve/Valve in Ring
14.30 - 15.00 Discussion
Concurrent Session IV: Basic Science to Elucidate Mechanisms of Valve Disease Keynote & Abstracts
Moderators: Elena Aikawa, MD
13:30 - 13:45 Keynote Speaker
Elena Aikawa, MD
13.45 - 13.55 A50. Cadherin-11 Coordinates Cellular Migration and Extracellular Matrix Remodeling During Aortic Valve Development and Promotes Calcification in Mature Aortic Valves
Derek C. Sung, Caitlin J. Bowen, Kiran A. Vaidya, Jonathan T. Butcher.
Cornell University, Meinig School of Biomedical Engineering, Ithaca, NY, USA.
13.55 - 14.05 A51. Overexpression Of Long Non-coding Rna During Calcific Aortic Valve Stenosis Promotes An Osteogenic Program By Modifying The Epigenetic Signature Of Notch1
Fayez Hadji1, Marie-Chloé Boulanger1, Émilie Lavoie-Charland1, Nathalie Gaudreault1, Sandra Guauque-Olarte1, Rihab Bouchareb1, Mohamed Nsaibia1, Luigi Bouchard2, Yohan Bossé1, Patrick Mathieu1.
1Quebec Heart and Lung Institute, Quebec, QC, Canada, 2Department of biochemistry, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada.
14.05 - 14.15 A52. Implication of Leptin in The Development of Calcific Aortic Valve Disease: Induction of Osteoblast Differentiation of Human Valvular Interstitial Cells Via the Akt And Erk Pathways
Mickael Rosa1, Rodrigo Lorenzi1, Ahmed Elkalioubie2, Madjid Tagzirt1, Ramadan Jashari3, Francis Juthier2, Antoine Rauch2, Anaïs Arbesu y Miar1, Delphine Corseaux1, André Vincentelli2, Bart Staels1, Eric Van Belle2, Sophie Susen2, Annabelle Dupont2.
1European Genomic Institute for Diabetes (E.G.I.D.), FR 3508, UNIV LILLE, Inserm UMR 1011; Institut Pasteur de Lille, F-59000, Lille, France, 2European Genomic Institute for Diabetes (E.G.I.D.), FR 3508, UNIV LILLE, Inserm UMR 1011; Institut Pasteur de Lille, F-59000, Cardiovascular and Pulmonary, and Haematology Department, CHRU de Lille, Lille, France, 3European Homograft Bank, c/o Military Hospital Queen Astrid, Brussels, Belgium.
14.15 - 14.25 A53. Shear-Sensitive miRNA-181b Impairs Anti-Inflammatory Signaling in the Aortic Valve Endothelium
Jack Heath, Joan Fernandez Esmerats, Rachel Simmons, Sandeep Kumar, Hanjoong Jo.
Emory University, Atlanta, GA, USA.
14.25 - 14.35 A54. A Role for the Retinoblastoma Pathway in Aortic Valve Disease
Marina Freytsis1, Lauren Baugh2, Phil Hinds1, Lauren Black2, Gordon Huggins3.
1Tufts University, Boston, MA, USA, 2Tufts University, Medford, MA, USA, 3Tufts Medical Center, Boston, MA, USA.
14.35 - 14.45 A55. GWAS of Aortic Stenosis (AS) in patients with Bicuspid Aortic Valve (BAV) Disease
Mahyar Heydarpour, PhD1, Vanessa Monteiro-Vieira, BSc1, Karam Habchi, BSc1, Jan Sliwa, MD2, Martin Sigurdsson, MD, PhD1, Jochen Muehlschlegel, MD, MMSc1, Prem Shekar, MD3, Eric Isselbacher, MD4, Thoralf Sundt, MD4, Simon Body, MBChB, MPH1.
1Brigham & Women's Hospital, Perioperative Genomics Center, Boston, MA, USA, 2Brigham & Women's Hospital, Cardiothoracic Anaesthesia, Boston, MA, USA, 3Brigham & Women's Hospital, Heart & Vascular Center, Boston, MA, USA, 4Massachusetts General Hospital, Corrigan Minehan Heart Center, Boston, MA, USA.
14.45 - 14.55 A56. Genetic Association and Functional Studies Identifies GLIS1 as A Risk Locus for Mitral Valve Prolapse
Christian Dina1, Nathan Tucker2, Francescaca Delling3, Susan Slaugenhaupt4, Robert A. Levine5, Albert A. Hagège6, Jean-Jacques Schott7, Xavier Jeunemaitre8, David Milan2, Russell Norris9, Nabila Bouatia-Naji10.
1Inserm UMR1087, CNRS UMR 6291, Institut du Thorax, Centre Hospitalier Universitaire (CHU), Nantes, France, 2Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA, 3Framingham Heart Study, Framingham, MA, USA, 4Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, 5Cardiac Ultrasound Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, 6AP-HP, Department of Cardiology, Hôpital Européen Georges Pompidou, INSERM UMR 970 l Européen Georges Pompidou, INSERM UMR970, Paris, France, 7Inserm UMR1087, CNRS UMR 6291, Institut du Thorax, Centre Hospitalier Universitaire (CHU) Nantes, Nantes,, Nantes, France, 8AP-HP, Departement of Genetics, Hopital Europeen Georges Pompidou, INSERM U970 Paris Cardiovascular Research Center, Paris, France, 9Cardiovascular Developmental Biology Center, Children's Research Institute, Medical University of South Carolinach Institute, Medical University of South Carolina, Charleston, SC, USA, 10INSERM UMR970 Paris Cardiovascular Research Center, Paris, France.
Concurrent Session V: Percutaneous Heart Valve Therapy Keynote & Abstracts
Moderator: Michael Mack, MD
13.30 - 13.45 Keynote
Michael Mack, MD
13.45 - 13.55 A57. Transcatheter Tricuspid Valve Repair: Initial Results from the Multicentre First-in-Man Feasibility Trial
Alec Vahanian1, Francesco Maisano2, Jean-Michel Juliard1, Ottavio Alfieri3, Antonio Colombo3, Antonio L. Bartorelli4, Francesco Alamanni4, Azeem Latib3.
1Hôpital Bichat, Université Paris-Diderot, Paris, France, 2University Hospital Zurich, Zurich, Switzerland, 3San Raffaele University Hospital, Milan, Italy, 4Centro Cardiologico Monzino, I.R.C.C.S., University of Milan, Milan, Italy.
13.55 - 14.05 A58. Crimp Induced Leaflet Damage and Calcification of Transcatheter Heart Valves
Aditi Sinha1, Oleksandr Barannyk2, Arash Kheradvar1.
1University of California, Irvine, Irvine, CA, USA, 2ViVitro Labs Inc, Victoria, BC, Canada.
14.05 - 14.15 A59. Transcatheter Replacement of Failed Bioprosthetic Valves: Comprehensive In-Vitro Bench Testing and Large In-Vivo Clinical Assessment of the Effect of Implantation Depth on Hemodynamics after Valve-in-Valve
Matheus Simonato1, John Webb1, Ran Kornowski2, Alec Vahanian3, Christian Frerker4, Henrik Nissen5, Sabine Bleiziffer6, Alison Duncan7, Guilherme F. Attizzani8, Eric Horlick9, Azeem Latib10, Raffi Bekeredjian11, Marco Barbanti12, Thierry Lefevre13, Alfredo Cerillo14, Jose Maria-Hernandez15, Giuseppe Bruschi16, Kostantinos Spargias17, Alessandro Iadanza18, Stephen Brecker19, Jose Honorio Palma20, Ariel Finkelstein21, Mohamed Abdel-Wahab22, Pedro Lemos23, Anna Sonia Petronio24, Didier Champagnac25, Jan-Malte Sinning26, Stefano Salizzoni27, Massimo Napodano28, Claudia Fiorina29, Antonio Marzocchi30, Martin Leon31, Danny Dvir1.
1St. Paul's Hospital, Vancouver, Canada; 2Rabin Medical Center, Petah Tivka, Israel; 3Hôpital Bichat-Claude Bernard, Paris, France; 4Asklepios Klinik, Hamburg, Germany; 5Odense University Hospital, Odense, Denmark; 6Deutsches Herzzentrum München, Munich, Germany; 7Royal Brompton and Harefield, London, United Kingdom; 8Case Western Research University, Cleveland, United States; 9Peter Munk Cardiac Centre, Toronto, Canada; 10Ospedale San Raffaelle, Milan, Italy; 11Universitätsklinikum Heidelberg, Heidelberg, Germany; 12Ospedale Ferrarotto, Catania, Italy; 13Hôpital Jacques Cartier, Massy, France; 14L'Ospedale del Cuore G. Pasquinucci, Massa, Italy; 15Hospital Universitario Virgen de la Victoria, Malaga, Spain; 16Ospedale Niguarda Ca' Granda, Milan, Italy; 17Hygeia Hospital, Athens, Greece; 18Azienda Ospedaliera Universitaria Senese, Siena, Italy; 19St. George's Hospital, London, United Kingdom; 20Escola Paulista de Medicina - UNIFESP, Sao Paulo, Brazil; 21Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; 22Segeberger Kliniken, Bad Segeberg, Germany; 23Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil; 24Università di Pisa, Pisa, Italy; 25Clinique du Tonkin, Villeurbanne, France; 26Universitätsklinikum Bonn, Bonn, Germany; 27Città della Salute e della Scienza - Molinette Hospital, Torino, Italy; 28Università degli Studi di Padova, Padova, Italy; 29Spedali Civili di Brescia, Brescia, Italy; 30Policlinico Sant'Orsola Malpighi, Bologna, Italy; 31Columbia University Medical Center, New York, United States.
14.15 - 14.25 A60. Mitral Valve Reconstruction with the Cardioband System: Results of the Multicentre Feasibility Trial
Francesco Maisano1, Karl-Heinz Kuck2, Ottavio Alfieri3, Antonio Colombo3, Stephan Baldus4, Alec Vahanian5, Georg Nickenig6.
1University Hospital Zurich, Zurich, Switzerland, 2Asklepios Klinik St. Georg Hospital, Hamburg, Germany, 3San Raffaele University Hospital, Milan, Italy, 4University Hospital Köln, Cologne, Germany, 5Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France, 6University Hospital Bonn, Bonn, Germany.
14.25 - 14.35 A61. Frame Flexibility Effects on Leaflet Stress Distribution: Comparison of Transcatheter versus Surgical Aortic Valve Bioprostheses
Mostafa Abbasi, Mohammed Barakat, Koohyar Vahidkhah, Ali Azadani.
University of Denver, Denver, CO, USA.
14.35 - 14.45 A62. Sinus Flow Stasis Occurs in Valve in Valve Transcatheter Aortic Valve Implantation
Lakshmi P. Dasi1, Hoda Hatoum1, Brandon Moore1, Pablo Maureira2, Juan Crestanello1.
1The Ohio State University, Columbus, OH, USA, 2Lorraine University Hospital of Nancy, Nancy, France.
14.45 - 14.55 A63. Systematic Transoesophageal Echocardiography after Mitral Valve Replacement - Prevalence and Determinants of Periprosthetic Leakage
Verdonk Constance.
Hopital Bichat, Paris, France.
15.00 - 15.30 Coffee Break & Poster Viewing
15.30 - 17.00 Concurrent Session I: Rapid Fire: Aortic Valve & Other Innovations
Moderator: Carlos Ruiz, MD
Eric Sarin, MD
Michael Borger, MD
Jeorg Seeburger, MD
In-Audience Moderators: Maurice Sarano, MD
Rakesh Suri, MD
5 min presentation.
15.30 – 15.35 Dangerous Calcium patterns high risk for root rupture
Jonathan Leipsic, MD
15.35 – 15.40 Valve in valve of a severely regurgitant bipoprosthesis
Amit Segev, MD
15.40 – 15.45 DirectFlow TAVR
Charles Davidson, MD
15.45 – 15.50 Portico TAVR
Gregory Fontana, MD
15.50 – 15.55 Jenavalve for aortic insufficiency
Sabine Bleiziffer, MD
15.55 – 16.00 I prefer the transapical approach for TAVR
Kevin Greason, MD
16.00 – 16.05 I can do trans-caval TAVR
Vasilis Babaliaros
16.05 – 16.10 I can do valve in valve in small prostheses
Norman Mangner, MD
16.10 – 16.15 The Claret device To avoid Stroke
Tamim Nazif, MD
16.15 – 16.20 Periprosthetic AR
Paul Sorajja, MD
16.20 – 16.25 Repositioning the TAVR
16.25 – 16.30 4Tech tricuspid technology
Denti Paolo, MD
16.30 – 17.00 Discussion
Concurrent Session II: Valve Disease Registries
Moderators: Hanneke Takkenberg, MD
Jolanda Kluin, MD
15.30 - 15.45 The MIDA Registry
Francesco Grigioni, MD
15.45 - 16.00 An Update on the Valve-In-Valve Registry
Danny Dvir, MD
16.00 - 16.15 AVIATOR: Lessons Learned and Challenges Ahead
Jolanda Kluin, MD
16.15 - 16.30 BAVCON
Simon Body, MD
16.30 - 17.00 Discussion
Concurrent Session III: Valve Cell Biology & Pathology
Moderators: Jane Grande-Allen, Ph.D.
Jonathan Butcher, MD
15.30 – 15.42 Microenvironmental Cues in the Regulation of Valvular Angiogenesis
Kristyn Masters, Ph.D.
15.42 – 15.54 The role of cell shape on valve interstitial cell biology and function
Kartik Balachandran, Ph.D.
15.54 – 16.06 Cellular heterogeneity in aortic valves: relevance for heart valve tissue engineering
Najma Latif, MD
16.06 – 16.18 Endotheliat mesenchymal transformation in fetal valve maturation and postnatal valve remodeling
Jonathan Butcher, MD
16.18 – 16.30 The basic science behind the phase II clinical trial of Ataciguat to treat moderate CAVD
Jordan Miller, MD
16.30 – 17.00 Discussion
Concurrent Session IV: Tricuspid Valve Disease
Moderator: Jerry Braun, MD
David Messika-Zeitoun, MD
15.30 - 15.45 Etiology and natural history of Tricuspid regurgitation
Hector Michelena, MD
15.45 - 16.00 Assessment and Quantification of Tricuspid Annulus and Regurgitation
David Messika-Zeitoun, MD
16.00 - 16.15 Organic and functional Tricuspid regurgitation, When and how to Operate
Jerry Braun, MD
16.15 - 16.30 Per-cutaneous Treatment of Tricuspid regurgitation - Where do we stand?
Amit Segev, MD
16.30 - 17.00 Discussion
Concurrent Session V: Atrial Fibrillation
Moderator: Peter Brady, MD
Hersh Maniar, MD
15.30 - 15.42 Hybrid Approaches to Stand-Alone AF, Ideal Patients and Real World Outcomes
Bart Maesen, MD, PhD
15.42 - 15.54 Concomitant Surgical Ablation in Patients Undergoing Valve Surgery: Risks, Benefits and Outcomes
Hersh Maniar, MD
15.54 - 16.06 Surgical MAZE: What Lesion Sets? What Outcomes?
Ralph Damiano Jr., MD
16.06 - 16.18 AF and Mitral Valve Surgery: When Not To Do A MAZE
Thierry Mesan, MD
16.18 - 16.30 Minimizing Stroke Risk in Patients with "Valvular" AF
Peter Brady, MD
16.30 - 17.00 Discussion
17.00 - 18.00 Hand-on Session
18:00 - 19:00 Faculty Reception
8:20 - 8:30 Award Presentations for Best Abstracts
Maurice E. Sarano, MD
Gilles D. Dreyfus, MD
Michael A. Borger, MD
Past President
8.30 - 10.00 Concurrent Session I: Case Studies I
Moderator: Maurice E. Sarano, MD
8.30 - 8.40 C1. Redo Transapical Procedure in a Calcified Transapical Edwards Sapien XT Prosthesis
Doreen Richardt, Thorsten Hanke, Holger Thiele, Hans H. Sievers, Thomas Kurz.
University Hospital of Schleswig-Holstein, Lübeck, Germany.
8.40 - 8.50 C2. Three-Dimensional Transoesophageal-Guided Transmitral Valve Implantation with a TENDYNE Device
Alison Duncan, Cesare Quarto, Simon Davies, Neil Moat.
The Royal Brompton Hospital, London, United Kingdom
8.50 - 9.00 C3. Reversible Thrombotic Aortic Restenosis After Valve-In-Valve Transcatheter Aortic Valve Replacement
Patrick J. Goleski, Creighton W. Don, MD.
University of Washington, Seattle, WA, USA.
9.00 - 9.10 C4. Hyper-acute Early Transcatheter Prosthesis Thrombosys In A Patient With Polycythemia Vera.
Laura Besola, Augusto D'Onofrio, Eleonora Bizzotto, Erica Manzan, Chiara Tessari, Gianbattista Isabella, Gaetano Thiene, Gino Gerosa.
University of Padua, Padua, Italy.
9.10 - 9.20 C5. Transcatheter Aortic Valve Replacement in Type B Aortic Dissection
Iosif Gulkarov1, Akanibo Da-Wariboko, MD1, Ashwad Afzal, MD1, Arash Salemi, MD2, Berhane Worku1.
1New York Methodist Hospital, Brooklyn, NY, USA, 2Weill Cornell Medical Center, New York, NY, USA.
9.20 - 9.30 C6. Multiple Valve Surgery For Advanced Rheumatic Heart Disease: Results And Risk Factors In 150 Patients
Zahira Zouizra, Yassin Boukaidi, Rachid El Houati, Drissi Boumzebra.
Ibn Tofail Hospital, MARRAKECH, Morocco.
9.30 - 9.40 C7. Progressive Aortic Valve Stenosis: is it all about the Calcium Deposition?
Geoffrey D. Huntley, B.A., Jeremy J. Thaden, M.D., Marie-Annick Clavel, D.V.M., Ph.D., Maurice E. Sarano, M.D., Vuyisile T. Nkomo, M.D., M.P.H..
Mayo Clinic, Rochester, MN, USA.
9.40 - 9.50 C8. Apical Left Ventricular Mycotic Aneurysm with Prosthetic Aortic Valve Endocarditis.
Kazuyoshi Takagi, Hiroyuki Otsuka, Koichi Arinaga, Koji Akasu, Tohru Takaseya, Takahiro Shojima, Yuichiro Hirata, Kumiko Wada, Satoshi Kikusaki, Keishi Hashimoto, Hiroyuki Tanaka.
Kurume University, Kurume, Japan.
9.50 - 10.00 C9. Concomitant Tricuspid Valve Replacement using an Extracellular Matrix Cylinder and Pulmonary Thromboembolectomy
Sreekumar Subramanian, MD, Joshua S. Hall, MSM, Bryan T. Fisher, Sr, MD.
TriStar Centennial Medical Center, Nashville, TN, USA.
Concurrent Session II: TAVR Imaging & Implementation
Moderators: Nicolo Piazza, Ph.D., MD
Mirkos Doss, MD
8.30 - 8.42 Pre-Procedure Screening
Jean Buithieu, MD
8.42 - 8.54 Intraprocedure Guidance
Nicolo Piazza, MD
8.54 - 9.06 Modeling of TAVR Implantation and Function
Wei Sun, PhD
9.06 - 9.18 Post Procedure Valve Assessment (e.g. Valve Thrombosis, Prosthetic Valve Function Evaluation)
Gregory Fontana, MD
9.18 - 9.30 Which Valve for Which Patient - A Tailored Imaging Approach
Mirkos Doss, MD
9.30 - 10.00 Discussion
Concurrent Session III: Biomechanics & Mechanobiology
Moderators: Michael Sacks, MD
Ajit Yoganathan, MD
8.30 - 8.42 Heart Valve Struction and Function: Implications for Valve Disease
Muralidhar Padala, MD
8.42 - 8.54 Multi-Scale Approaches to Heart Valve Function
Michael Sacks, MD
8.54 - 9.06 Heart Valve Biomechanics
Ajit P. Yoganathan, MD
9.06 - 9.18 Heart Valve Extracellular Matrix Function and Performance
Jane Grande-Allen, MD
9.18 - 9.30 Heart Valve Cellular Function
Craig Simmons, MD
9.30 - 10.00 Discussion
Concurrent Session IV: Valve Repair Network
Moderators: Michael Borger, MD
Rakesh Suri, MD
8.30 – 8.42 Mitral Valve Repair: A Success Story
Gilles D. Dreyfus, MD
8.42 – 8.54 Aortic Valve Repair: Have We Reached the Limit?
Jean Louis Vanoverschelde, MD
8.54 – 9.06 Mitral Repair Network: Critical hemodynamic and LV measures to include
9.06 – 9.18 Anatomic and functional mitral characteristics indispensable to consider in a valve research network
Ottavio Alfieri, MD
9.18 – 9.30 Starting a Valve Repair Network: Lessons Learned
Emmanuel Lansac, MD
9.30 – 10.00 Discussion
Concurrent Session V: Ross/Homograft
Moderators: Hanneke Takkenberg, MD
Ismail El-Hamamsy, MD
8.30 - 8.45 Surgical Techniques for Pulmonary Autograft Implantation in Adult Patients
Peter Skillington, MD
8.45 - 9.00 Pediatric Ross Operation: Late Outcomes and Determinants of Homograft Durability
Hanneke Takkenberg, MD
9.00 - 9.15 Reoperations After the Ross Procedure: Challenges and Opportunities
Giovanni Battista Luciani, MD
9.15 - 9.30 Toward a Successful Ross Program: Sharing Experiences
Ismail El-Hamamsy, MD
9.30 - 10.00 Discussion
10.30 - 12.00 Concurrent Session I: Case Studies II
Moderator: Maurice E. Sarano, MD
10.30 - 10.40 C10. The Challenge of Sizing Valsalva Prostheses for Autograft Reinforcement in the Ross Procedure
Alfred Kocher, Claudia Oeser, Martin Andreas, Guenther Laufer.
Medical University of Vienna, Vienna, Austria.
10.40 - 10.50 C11. Right Atrial Myxoma Clinically Mimicking Recurrence Of Mitral Valve Stenosis After Open Mitral Valve Repair For Rheumatic Severe Mitral Stenosis.
Gauranga Majumdar, Surendra Agarwal, Shantanu Pande, Bipin Chandra.
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
10.50 - 11.00 C12. Successful Bailout Transcatheter Valve Implantation for Prosthetic Aortic Valve Endocarditis During Open Re-do Surgery
Lorenz Hansen, MD, Klaudija Bijuklic, MD, Jan-Hendrik Stripling, MD, Joachim Schofer, MD, PHD, Friedrich-Christian Rieß, MD, PHD.
Albertinen-Krankenhaus, Hamburg, Germany.
11.00 - 11.10 C13. Importance of the Prosthesis Choice in the Valve-in-Valve Era: Role of the Sutureless Perceval Valve
Stefano Moriggia, Igor Belluschi, Andrea Blasio, Nicola Buzzatti, Fabrizio Monaco, Ottavio Alfieri.
San Raffaele University Hospital, Milan, Italy.
11.10 - 11.20 C14. 3d TOE-guided Mitral Valve-in-Valve Procedure
Alison Duncan, Cesare Quarto, Simon Davies, Neil Moat.
The Royal Brompton Hospital, London, United Kingdom.
11.20 - 11.30 C15. Transcatheter Mitral Valve-in-Ring Replacement: A Novel Therapy in a Challenging Case of Symptomatic Mitral Regurgitation
Risheen S. Reejhsinghani, Lucas S. Zier, Mark L. Villalon, Scot H. Merrick, Georg M. Wieselthaler, Atif N. Qasim, Vaikom S. Mahadevan.
University of California, San Francisco, San Francisco, CA, USA.
11.30 - 11.40 C16. Double-Sided Mitral Valve Repair: Transventricular Approach Augmented By Undersized Annuloplasty Via Conventional Left Atriotomy
Kerim Cagli, MD1, Ali Baran Budak, MD2, Kemal Korkmaz, MD2, Hikmet Selcuk Gedik, MD2, Eren Gunertem, MD1, Omer Cicek, MD1, Gokhan Lafci, MD1, Serdar Gunaydin, MD, PhD2.
1Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey, 2Numune Training and Research Hospital, Ankara, Turkey.
11.40 - 11.50 C17. Transapical Mitral Valve In Ring Procedure: Intraoperative Challenge And Late Complication
Laura Besola, Augusto D'Onofrio, Erica Manzan, Eleonora Bizzotto, Chiara Tessari, Tomaso Bottio, Giuseppe Tarantini, Gino Gerosa.
University of Padua, Padua, Italy.
11.50 - 12.00 C18. Late presentation of Annular Rupture Initially Mimicking Prosthesis Dysfunction after Transcatheter Aortic Valve Implantation.
Sami M. Alnasser, Christopher Fiendle, Jennifer Day, Mark Osten, Robert J Cusimano, Ashish Shah, Eric Horlick.
Peter Munk Cardiac Center, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.
Concurrent Session II: Mitraclip Imaging & Implementation
Moderators: Paul Sorajja, MD
Madalina Garbi, MD
10.30 - 10.38 How do I know it's on label DMR?
Muhamed Saric, MD
10.38 - 10.46 Differences in Mitraclip technique for DMR vs. FMR
Magnus Settergren, MD
10.46 - 10.54 Unconventional imaging for MitraClip therapy
Rebecca Hahn, MD
11.02 - 11.10 The benefit of implanting multiple clips
Francisco Maisano, MD
11.10 - 11.18 I only need transthoracic echo to guide the procedure
Mani Vannan, MD
11.18 - 11.26 My hardest case as a Mitraclip expert
Saibal Kar, MD
11.26 - 11.32 A surgeon's perspective on performing Mitraclip
Joerg Seeburger, MD
11.32 - 12.00 Discussion
Concurrent Session III: Ventricular Hemodynamics: Imaging & Modeling
Moderators: Arash Kheradvar, MD
Sorin Pislaru, MD
Jim Thomas, MD
Blasé Carabello, MD
10.30 - 10.45 The role of invasive hemodynamics in the world of advanced imaging
Blasé Carabello, MD
10.45 - 11.00 Deformation imaging in valvular heart disease: ready for prime time
Sorin Pislaru, MD
11.00 - 11.15 The most common imaging pitfalls in VHD: How can we be more quantitative?
Jim Thomas, MD
11.15 - 11.30 Image-based modeling of hemodynamic in heart valve disease
Arash Kheradvar, MD
11.30 - 12.00 Discussion
Concurrent Session IV: InterAmerican Cardiac Society Collaborative Session
Moderators: Jose Pomar, MD
Gustavo Restrepo, MD
10.30 - 10.42 Echo Screening for Rheumatic Valve Heart Disease: Where Are We?
Andrea Beaton, MD
10.42 - 10.54 Time to Intervention in Rheumatic Mitral Valve Disease
Flavio Tarasoutchi, MD
10.54 - 11.06 Balloon Mitral Valvuloplasty: Going Beyond Valve Morphology
Marcia Barbosa, MD
11.06 - 11.18 Rheumatic Mitral Valve Regurgitation: Can It Be Repaired?
Taweesak Chotivatanapong, MD
11.18 - 11.30 Are We Always Offering the Best to Our Patients? Same in Every Country?
Jose Pomar, MD
11.30 - 12.00 Discussion
Concurrent Session V: Minimally Invasive & Robotic Surgery
Moderators: Rakesh Suri, MD
Doug Murphy, MD
10.30 - 10.42 Mitral valve repair: the science behind early repair
Theirry Le Tourneau, MD
10.42 - 10.54 Who are the candidates for robotic mitral repair and how do I set up the operation?
Tomislav Mihaljevic, MD
10.54 - 11.06 Robotic repair for all categories of leaflet prolapse complexity?
Robinson Poffo, MD
11.06 - 11.18 What are the short and mid-term outcomes?
Michael Halkos, MD
11.18 - 11.30 Who Should Undertake the Establishment of a Robotic Program?
Vinay Bhadwar, MD
11.30 - 11.42 My Toughest Robotic Mitral Valve Repair
Emiliano Navarra, MD
11.42 - 12.00 Discussion